A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope ® ) During a Phase III Clinical Trial

Conclusion This cohort of Spanish patients with GHD showed a positive response to rhGH treatment, achieving adult height within the local normal ranges. In addition, rhGH treatment was well tolerated, with no new or additional safety concerns.

http://link.springer.com/10.1007/s12325-015-0181-9

Source: Advances in Therapy - February 10, 2015 Category: Drugs & Pharmacology Source Type: research